Stanford study of dark-skinned mice leads to protein linked to bone marrow failure in humans
The study of dark-skinned mice has led to a surprising finding about a common protein involved in tumor suppression, report researchers at the Stanford University School of Medicine. The results may lead to new treatments for bone marrow failure in humans.
The rest of the article can be read here.
Related Posts:- Protein key to control, growth of blood cells
- Researchers grow human blood vessels in mice from adult progenitor cells
- Bone marrow stem cells may help control inflammatory bowel disease
- Nerve Cells Derived From Stem Cells And Transplanted Into Mice May Lead To Improved Brain Treatments
- Cancer ‘cure’ in mice to be tested in humans
- Small protein may have big role in making more bone and less fat
- Cancer drug shows promise against graft vs. host disease
- Rapid changes in key Alzheimer’s protein described in humans
- Penn study finds way to prevent protein clumping characteristic of Parkinson’s disease
- Facebook concepts indicate brains of Alzheimer’s patients aren’t as networked, Stanford study shows
You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.
Leave a Reply